June 27, 2021
2 mins read

Serum begins Covovax production

SII’s Phase-2 and 3 clinical trials of Covovax will reportedly be conducted in 920 children — 460 each in 12-17 years and 2-11 years groups, media reports said…reports Asian Lite News

The Pune-based Serum Institute of India (SII) has begun manufacturing Novavax’s protein-based vaccine Covovax, CEO Adar Poonawalla has said.

The company will also begin clinical trials of Novavax for children starting July.

“Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune,” he shared in a tweet on Friday.

In the recently released Phase -3 trials, Covovax has shown overall 90 per cent efficacy against Covid-19. The US-based trials also demonstrated the two-shot vaccine 100 per cent protection against moderate and severe disease.

“The vaccine has great potential to protect our future generations below the age of 18. Trials are ongoing. Well done team,” he said.

SII’s Phase-2 and 3 clinical trials of Covovax will reportedly be conducted in 920 children — 460 each in 12-17 years and 2-11 years groups, media reports said.

In August 2020, Novavax and SII had announced an agreement under which the US biotechnology company had given SII the licence to manufacture and supply the vaccine in low- and middle-income countries.

In March 2021, CEO Poonawalla said Covovax will be launched by September this year.

“Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India,” said Adar Poonawalla. “Hope to launch by September 2021!” the CEO of the world’s biggest Covid-19 vaccine maker had said.

Recently, the Centre stated that Novavax Covid vaccine efficacy data in a large trial are promising and that clinical trials are being conducted and are in an advanced stage of completion in India.

“What we’re learning from data available in the public domain is that this vaccine is very safe and highly effective,” Dr V.K. Paul, NITI Aayog Member (Health) said earlier this month.

The company intends to file for regulatory authorisations in the third quarter, upon completion of the final phases of process qualification and assay validation needed to meet chemistry, manufacturing and controls (CMC) requirements.

Upon regulatory approvals, Novavax remains on track to reach a manufacturing capacity of 100 million doses per month by the end of the third quarter and 150 million doses per month by the end of the fourth quarter of 2021.

Hyderabad-based Bharat Biotech has also two vaccines that are being tried on children, Covaxin and BBV154, a one-shot nasal vaccine.

ZyCov-D, the Zydus’ Covid-19 vaccine has also started trials on children in the age group 12-18 years.

The government is also considering providing legal indemnity to Pfizer and Moderna to roll out their vaccines in India. Pfizer has announced that its vaccine is safe for children above 12 years of age.

ALSO READ-Serum Institute says Covishield is most affordable jab

READ MORE-Serum Institute to start vaccine production in London

Previous Story

IAF chief begins Bangladesh visit

Next Story

The Wahhabi Factor of Kashmir Issue

Latest from -Top News

Sudan army pulls out as RSF seizes El-Fasher

al-Burhan made the announcement late on Monday, a day after the RSF claimed to have captured the main Sudanese army base in el-Fasher….reports Asian Lite News Sudan’s army chief, General Abdel Fattah

India vigilant as Nepal faces political uncertainty

Indian agencies suspect that external elements are making attempts to create a political vacuum in the country. …reports Asian Lite News India is closely monitoring political developments in Nepal, emphasising that stability

India vows stronger maritime ties with ASEAN

Conveying Prime Minister Narendra Modi’s warm greetings on the 20th anniversary of the East Asia Summit (EAS), he said India deeply values the members’ contributions to regional peace, progress, and prosperity….reports Asian

Piyush Goyal in Brussels as India, EU push FTA talks

Goyal’s visit reflects India’s steadfast commitment to deepening engagement with the European Union…reports Asian Lite News Commerce and Industry Minister Piyush Goyal on Monday met EU Commissioner for Trade and Economic Security

Shutdown Turmoil Grounds Thousands of US Flights

On Sunday alone, over 8,700 flights were delayed, according to FlightAware, as staffing shortfalls continue to mount…reports Asian Lite News More than 4,000 flights across the US were delayed on Monday, with
Go toTop

Don't Miss

MEA says overseas vaccine supply will depend on availability

India’s immediate priority is to use made in India vaccines

India achieves single-day record of 1.09 cr vaccinations

In wake of the incident, the state government has now